Fisher & Paykel Healthcare (NZSE:FPH) EPS (Basic): NZ$0.80 (TTM As of Mar. 2026)


NZSE:FPH Fisher & Paykel Healthcare Corp Ltd NZSE:FPH
91 GF Score
Price NZ$37.50
GF Value NZ$44.33
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Fisher & Paykel Healthcare EPS (Basic)?

Fisher & Paykel Healthcare NZSE:FPH -0.29% 91 EPS (Basic) is NZ$0.80 as of Mar. 2026. GuruFocus rates NZSE:FPH with a GF Score™ of 91/100 and a GF Value™ of NZ$44.33 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Fisher & Paykel Healthcare's basic earnings per share (Basic EPS) for the six months ended in Mar. 2026 was NZ$0.44. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.80.

Fisher & Paykel Healthcare's EPS (Diluted) for the six months ended in Mar. 2026 was NZ$0.43. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.79.

Fisher & Paykel Healthcare's EPS without NRI for the six months ended in Mar. 2026 was NZ$0.43. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.79.

During the past 12 months, Fisher & Paykel Healthcare's average EPS without NRIGrowth Rate was 24.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 22.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was -3.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Fisher & Paykel Healthcare's highest 3-Year average EPS without NRI Growth Rate was 76.20% per year. The lowest was -37.00% per year. And the median was 13.00% per year.

Fisher & Paykel Healthcare  (NZSE:FPH) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Fisher & Paykel Healthcare EPS (Basic) Related Terms

Fisher & Paykel Healthcare EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Fisher & Paykel Healthcare's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fisher & Paykel Healthcare EPS (Basic) Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 0.43 0.23 0.64 0.80

Fisher & Paykel Healthcare Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.26 0.38 0.36 0.44
NZSE:FPH
91GF Score
Fisher & Paykel Healthcare Corp Ltd NZSE:FPH
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fisher & Paykel Healthcare EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Fisher & Paykel Healthcare's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(468.5-0)/586.929
=0.80

Fisher & Paykel Healthcare's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(255.5-0)/587.270
=0.44

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of NZ$0.80 mean?
Fisher & Paykel Healthcare (NZSE:FPH) has a EPS (Basic) of NZ$0.80 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Fisher & Paykel Healthcare and its competitors.
Is Fisher & Paykel Healthcare's EPS (Basic) too high?
Fisher & Paykel Healthcare's current EPS (Basic) is NZ$0.80. Overall, Fisher & Paykel Healthcare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's EPS (Basic) compare to ISRG and BDX?
Fisher & Paykel Healthcare's EPS (Basic) of NZ$0.80 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Fisher & Paykel Healthcare and its competitors. Fisher & Paykel Healthcare's current EPS (Basic) is NZ$0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (NZSE:FPH) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$44.33, compared to a current price of NZ$37.50 — trading 15.4% below its estimated fair value. The current EPS (Basic) is NZ$0.80. Fisher & Paykel Healthcare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Fisher & Paykel Healthcare (NZSE:FPH), the current EPS (Basic) is NZ$0.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fisher & Paykel Healthcare (NZSE:FPH) Overvalued in 2026?

Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued. The current stock price of NZ$37.50 is trading 15.4% below its estimated GF Value™ of NZ$44.33. GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.

Key valuation signals for NZSE:FPH:

  • EPS (Basic): NZ$0.80
  • GF Value™: NZ$44.33 vs. price of NZ$37.50 (15.4% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the NZSE:FPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fisher & Paykel Healthcare Business Description

Other Exchanges FSPKF:USAFPH:Australia
Address 15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
91GF Score

Get the complete analysis for NZSE:FPH

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$37.50
Price
NZ$44.33
GF Value